167 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
Rank Status Study
21 Unknown  Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Conditions: Leishmaniasis;   Leishmaniasis, Mucocutaneous
Intervention: Drug: Miltefosine
22 Recruiting Protocol TARC-ABPA
Condition: Allergic Broncho-Pulmonary Aspergillosis
Intervention: Other: Study of predictive factors
23 Unknown  Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
Conditions: Invasive Fungal Infection;   Aspergillosis;   Fungemia;   Hematopoietic Stem Cell Transplantation
Intervention:
24 Recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
Conditions: Visceral Leishmaniasis;   Human African Trypanosomiasis;   Enteric Fever;   Melioidosis;   Brucellosis;   Leptospirosis;   Relapsing Fever;   Rickettsial Diseases;   HIV;   Tuberculosis;   Malaria;   Amoebic Liver Abscess
Interventions: Device: rk28 ICT;   Device: IT LEISH (rK39);   Device: Immunochromatographic HAT test;   Device: HAT Serostrip;   Device: Card Agglutination Trypanosoma Test (CATT)-10;   Device: Typhidot M;   Device: S. typhi IgM/IgG;   Device: Test-it Typhoid IgM;   Device: Test-it Leptospirosis IgM;   Device: Leptospira IgG/IgM
25 Recruiting Host Response to Infection and Treatment in Filarial Diseases
Conditions: Filariasis;   Helminthiasis;   Loiasis;   Mansonelliasis;   Onchocerciasis
Intervention:
26 Recruiting Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts
Condition: Plantar Wart
Interventions: Drug: Pyruvic acid;   Drug: Salicylic Acid
27 Not yet recruiting Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts
Condition: External Genital Warts
Interventions: Drug: 15% AS101 gel;   Drug: Vehicle
28 Recruiting Doxycycline in Therapy of Erythema Migrans
Condition: Lyme Borreliosis
Intervention: Drug: Doxycycline
29 Recruiting Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal Amphotericin B;   Drug: Miltefosine
30 Recruiting Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers
Condition: Visceral Leishmaniasis
Interventions: Biological: LEISH-F3 + SLA-SE;   Biological: LEISH-F3 + GLA-SE
31 Unknown  A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Conditions: Genital Warts;   HPV
Interventions: Drug: Oral Zinc;   Drug: Placebo
32 Recruiting Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration
33 Unknown  Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis
Intervention:
34 Unknown  Treating Onychomychosis
Condition: Onychomycosis
Intervention: Device: Noveon laser
35 Recruiting Pilot Study to Evaluate Plasma Treatment of Onychomycosis
Condition: Onychomycosis
Intervention: Device: MOE Antimicrobial Plasma Treatment System
36 Unknown  Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord
Conditions: Infection;   Skin Diseases, Bacterial;   Granuloma
Interventions: Behavioral: Hygiene;   Procedure: Usual alcohol care
37 Unknown  Diagnosis of Invasive Pulmonary Aspergillosis by Direct Lung Tissue Aspergillus Galactomannan Antigen Detection From Aspirate by Ultrasound-guided Fine Needle Aspiration
Condition: Immunocompromised
Intervention: Procedure: Lung aspiration
38 Recruiting Pulsed Dye Laser Treatment of Onychomycosis
Condition: Onychomycosis
Intervention: Device: Pulsed Dye Laser for the treatment of nail fungus
39 Unknown  Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B;   Drug: liposomal amphotericin B + miltefosine;   Drug: liposomal amphotericin B + paromomycin;   Drug: Miltefosine + Paromomycin
40 Recruiting A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Other: Blood draw;   Other: Nasopharyngeal wash

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years